JPRN-UMIN000045721
Recruiting
Phase 2
Phase II study of stereotactic radiotherapy for kidney cancer using an MR-Linac system - MR-Linac based stereotactic radiotherapy for kidney cancer
ConditionsKidney cancer(primary kidney cancer)
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Kidney cancer(primary kidney cancer)
- Sponsor
- Tohoku University
- Enrollment
- 25
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •(1\)Radiation oncologists judge not to have a tolerance or not to be suitable for stereotacitc radiotherapy because of coexisting illness (2\)Double cancer or past history of double cancer within 3 years. (3\)Implanted metal in the body (4\)Mental disorder, especially claustrophobiady (5\)Infection (6\)Pregnant or lactating woman, likelihood of pregnancy
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 1
Phase I/II study of stereotactic radiotherapy for renal cell cancerJPRN-UMIN000004172niversity of Yamanashi30
Completed
Phase 2
Phase II study of stereotactic radiotherapy with volumetric modulated arc therapy for primary lung cancer located adjacent to organ at riskJPRN-UMIN000022856Department of Radiuation Oncology, Tohoku University Graduate School of Medicine15
Completed
Phase 2
Phase II trial of stereotactic body radiotherapy with a hydrogel spacer for prostate cancerProstate cancerJPRN-UMIN000026213The University of Tokyo Hospital42
Completed
Not Applicable
Phase II trial of stereotactic body radiotherapy for non-spine bone metastases.non-spine bone metastasesJPRN-UMIN000033132Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital35
Recruiting
Phase 1
Phase I study of postoperative stereotactic body radiotherapy for prostate cancerJPRN-jRCT1030220062Yamashita Hideomi36